ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Immunome at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Immunome takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8017. Its session covers how drug exposure relates to response in desmoid tumours. The analysis supports a recommended dose of varegacestat.

OrganizationESMO 2026 Attendance
BiotechExhibitor
US biotech developing targeted cancer therapies, including antibody-drug conjugates and a gamma secretase inhibitor for desmoid tumours.
Booth
Exhibiting at Booth 8017
Poster
Mon Oct 26
12:00–12:45
Exposure-response (ER) analyses to support the recommended dose of varegacestat (VAR) for patients (pts) with desmoid tumors (DT)
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Immunome

Tell us what you sell and we’ll find the people at Immunome most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction